Webيعرض السوق العالمي مسحوق كلوريد الزنك الذي تمت إضافته بواسطة MarketQuest.biz معلومات أصلية حول السوق إلى جانب التوقعات لمدة 2024-2029. WebMost Recent Annual Report. MOST RECENT 2024 Annual Report and Form 10K. View PDF View Form 10K (HTML) Inovio Pharmaceuticals, Inc. does not currently have any …
INOVIO Reports Second Quarter 2024 Financial Results
WebMar 1, 2024 · Inovio Pharmaceuticals press release (NASDAQ:INO): FY GAAP EPS of -$1.17 misses by $0.06.Revenue of $10.26M (+479.7% Y/Y) misses by $0.29M. Seeking Alpha - Go to Homepage Entering text into the ... WebSector Industry Market Cap Revenue; Medical: Medical - Biomedical and Genetics: $0.477B: $0.002B: Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. criselda cecilio
Inovio Pharmaceuticals Probability Of Bankruptcy (NASDAQ:INO) …
WebTotal Enterprise Value to Total Revenue (ttm) 13.19. Markets data provided by S&P and by Xignite. Profitability Metrics. Gross Margin (ttm) N/A. ... The stock price of Inovio Pharmaceuticals, a ... WebRevenue; Medical: Medical - Biomedical and Genetics: $0.278B: $0.010B: Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the … WebMar 1, 2024 · INOVIO's net loss for the quarter and year ended December 31, 2024 was $106.9 million, or $0.50 per basic and diluted share, and $303.7 million, or $1.45 per basic and diluted share, respectively, compared to net loss of $24.3 million, or $0.14 per basic … At INOVIO, we promise to treat your data with respect and will not share your … mancave.com baseball colorized